Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BRISTOL MYERS SQUIBB

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 6

FDA approve APIXABAN

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 5

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 5

FDA approve ESOMEPRAZOLE SODIUM

Comment Full text

SUNSHINE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 7

FDA approve TICAGRELOR

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 4

FDA approve RANOLAZINE

Comment Full text

ALCON LABS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 8

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 7

FDA approve OLMESARTAN MEDOXOMIL

Comment Full text

STIRA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 7

FDA approve ZINC CHLORIDE

Comment Full text

ALCON LABS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 7

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

RECORDATI RARE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 8

FDA approve OSILODROSTAT PHOSPHATE

Comment Full text
  • Previous
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next

Search

News categories

  • Technical Exchange News(9055)
  • Event(407)
  • SEC News(143280)
  • FDA Approval(8415)
  • Company Report(721)
  • Business News(100332)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin